Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | AR | P10275 | 9/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9360921 | 1.00 | CYP19A1 (0.49) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL10352808 | 0.79 | CYP19A1 (0.50) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL29390509 | 0.78 | CYP19A1 (0.65) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL4581525 | 0.78 | CYP19A1 (0.65) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL3230901 | 0.77 | PDE4A (0.41) | PDE4BAR | |
| SCHEMBL9472016 | 0.76 | CYP19A1 (0.62) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL1377229 | 0.76 | CYP19A1 (0.62) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL8471918 | 0.75 | MGMT (0.37) | ALDH1A1MAOA | |
| SCHEMBL1374021 | 0.74 | CYP19A1 (0.67) | CYP19A1MAOBALDH1A1HPGDNPSR1 | |
| SCHEMBL5145150 | 0.74 | CYP19A1 (0.67) | CYP19A1MAOBALDH1A1HPGDNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107382986-B | 4-hydroxy-1-methylisoquinoline derivatives and their use in increasing endogenous erythropoietin | 江苏艾立康医药科技有限公司 | 2022-09-20 | — | — | CN | disclosed |